BTSA1, a direct pharmacological BAX activator that induces the conformational transformation of BAX, effectively promotes apoptosis in acute myeloid leukemia and multitype solid tumor cell lines (Lopez et al., 2022; Reyna et al., 2017; Zhang, Zhao, et al., 2023). The gene discussed is BAX; the disease is acute myeloid leukemia.